Nakayama Hitomi

Affiliation and department：

Research field (1)： Hematology and oncology

Papers (12)：

Hitomi Nakayama, Rie Yamazaki, Jun Kato, Yuya Koda, Masatoshi Sakurai, Takehiko Mori. Impact of Specific Antibody Level on Human Herpesvirus 6 Reactivation after Allogeneic Stem Cell Transplantation. Transplantation and cellular therapy. 2021. 27. 2. 174.e1-174.e5
Hitomi Nakayama, Jun Kato, Taku Kikuchi, Mikio Okayama, Takahiro Kamiya, Kota Mizuno, Takayuki Shimizu, Shinichiro Okamoto, Takehiko Mori. [Systemic varicella-zoster infection during ixazomib-containing multiagent chemotherapy for multiple myeloma]. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2020. 61. 8. 870-873
Hitomi Nakayama, Rie Yamazaki, Jun Kato, Yuya Koda, Masatoshi Sakurai, Ryohei Abe, Shintaro Watanuki, Chieko Sumiya, Kohei Shiroshita, Shinya Fujita, et al. Erratum to: Human Herpesvirus 6 Reactivation Evaluated by Digital Polymerase Chain Reaction and Its Association With Dynamics of CD134-Positive T Cells After Allogeneic Hematopoietic Stem Cell Transplantation. The Journal of infectious diseases. 2019. 221. 11. 1917-1917
Takehiko Mori, Taku Kikuchi, Jun Kato, Yuya Koda, Masatoshi Sakurai, Osamu Kikumi, Rika Inose, Mitsuru Murata, Naoki Hasegawa, Hitomi Nakayama, et al. Seasonal changes in indoor airborne fungal concentration in a hematology ward. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2019
Kohei Shiroshita, Takehiko Mori, Jun Kato, Masatoshi Sakurai, Yuya Koda, Ryohei Abe, Koichi Murakami, Chieko Sumiya, Shinya Fujita, Kentaro Yamaguchi, et al. Clinical characteristics of human herpesvirus-6 myelitis after allogeneic hematopoietic stem cell transplantation and its favorable outcome by early intervention. Bone marrow transplantation. 2019. 55. 5. 939-945

ｍore...

MISC (6)：

Kohei Shinmura, So Okubo, Saori Kadota, Hitomi Nakayama, Aki Sakurai, Shuhei Kurosawa, Chisako Ito, Yoshinobu Aisa, Tomonori Nakazato. Polatuzumab vedotin plus bendamustine and rituximab (Pola-BR) was effective for neurolymphomatosis in a patient with refractory diffuse large B-cell lymphoma. Annals of hematology. 2023. 102. 1. 223-225
中山瞳, 山崎理絵, 山崎理絵, 加藤淳, 甲田祐也, 櫻井政寿, 城下郊平, 藤田進也, 山口健太郎, 水野洸太, et al. 同種造血幹細胞移植後HHV-6再活性化におけるCD134陽性T細胞の影響. 日本血液学会学術集会抄録(Web). 2020. 82nd
城下郊平, 甲田祐也, 櫻井政寿, 綿貫慎太郎, 山崎理絵, 中山瞳, 加藤淳, 岡本真一郎, 森毅彦. 同種造血幹細胞移植後に発症したHHV-6脊髄炎症例の後方視的検討. 日本造血細胞移植学会総会プログラム・抄録集. 2019. 41st
中山瞳, 山崎理絵, 加藤淳, 甲田祐也, 櫻井政寿, 安部涼平, 城下郊平, 住谷智恵子, 山口健太郎, 岡本真一郎, et al. 同種造血幹細胞移植後HHV-6再活性化におけるCD134陽性T細胞の影響. 日本造血細胞移植学会総会プログラム・抄録集. 2019. 41st
綿貫慎太郎, 菊池拓, 外山高朗, 安部涼平, 中山瞳, 雁金大樹, 菊池潤, 清水隆之, 森毅彦, 岡本真一郎. ダサチニブ内服中肺高血圧(PH)から混合性結合組織病(MCTD)と診断した慢性骨髄性白血病(CML). 臨床血液. 2017. 58. 8. 1077-1077

ｍore...

Association Membership(s) (4)：

日本造血細胞移植学会 , JAPANESE SOCIETY OF LABORATORY MEDICINE , THE JAPANESE SOCIETY OF HEMATOLOGY , THE JAPANESE SOCIETY OF INTERNAL MEDICINE

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page